{
    "Trade/Device Name(s)": [
        "Psychemedics Homogeneous Enzyme Immunoassay for Cocaine in Hair"
    ],
    "Submitter Information": "Psychemedics Corporation",
    "510(k) Number": "K201228",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111925"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXO"
    ],
    "Summary Letter Date": "June 25, 2021",
    "Summary Letter Received Date": "October 27, 2020",
    "Submission Date": "October 26, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.3250"
    ],
    "Regulation Name(s)": [
        "Cocaine and Cocaine Metabolite Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Cocaine"
    ],
    "Specimen Type(s)": [
        "Human head hair",
        "Human body hair"
    ],
    "Specimen Container(s)": [
        "V-shaped aluminum foil sample holder",
        "Sample acquisition card envelope"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Homogeneous enzyme immunoassay",
        "Spectrophotometric detection at 340 nm"
    ],
    "Methodologies": [
        "Qualitative drug detection",
        "Phosphate buffer hair extraction"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Psychemedics Homogeneous Enzyme Immunoassay for preliminary qualitative detection of cocaine in human hair specimens",
    "Indications for Use Summary": "Preliminary qualitative detection of cocaine in human head and body hair for identifying cocaine use, intended exclusively for in-house professional use; positive results require confirmation with a more specific alternate chemical method (e.g., LC/MS/MS).",
    "fda_folder": "Toxicology"
}